Results 321 to 330 of about 2,377,300 (402)

Cost-utility analysis of romiplostim for the treatment of chronic primary immune thrombocytopenia in China. [PDF]

Intractable Rare Dis Res
Luo Y, Cheng W, Fu Y, Wang H, Wang H.
europepmc   +1 more source

A Cost-Utility Analysis of the Use of -125 mm Hg Closed-incision Negative Pressure Therapy in Oncoplastic Breast Surgery. [PDF]

Plast Reconstr Surg Glob Open
Bloom JA, Wareham C, Chahine E, Singhal D, Lin SJ, Lee BT, Nardello S, Homsy C, Persing SM, Chatterjee A.   +9 more
europepmc   +1 more source

Cost-utility analysis of ropeginterferon alfa-2b to manage low-risk patients with polycythemia vera as compared to phlebotomy only in the Austrian healthcare system. [PDF]

Ann Hematol
Walter E, Torelli F, Barbui T.
europepmc   +1 more source

A Nationwide Physical Activity Intervention for 654,500 Adults in Singapore: Cost-Utility Analysis.

JMIR Public Health Surveill
Ang G, Tan CS, Teerawattananon Y, Müller-Riemenschneider F, Chen C.   +4 more
europepmc   +1 more source

WCN25-1401 COST UTILITY ANALYSIS COMPARING EXPANDED AND HIGH-FLUX HEMODIALYSIS

Kidney International Reports
Angela Rivera, Quitian Hoover, Fabiola Andrea Aldana, Mauricio Sanabria, Peter Rutherford   +4 more
doaj